title: Role of liposomal daunorubicin, fludarabine and cytarabine (FLAD) in the salvage therapy of adult acute lymphoblastic leukemia.
authors.forename: Marino
authors.initials: M
authors.lastname: Clavio
authors.forename: Ivana
authors.initials: I
authors.lastname: Pierri
authors.forename: Claudia
authors.initials: C
authors.lastname: Venturino
authors.forename: Alberto
authors.initials: A
authors.lastname: Garrone
authors.forename: Letizia
authors.initials: L
authors.lastname: Canepa
authors.forename: Maurizio
authors.initials: M
authors.lastname: Miglino
authors.forename: Riccardo
authors.initials: R
authors.lastname: Varaldo
authors.forename: Filippo
authors.initials: F
authors.lastname: Ballerini
authors.forename: Gian Luca
authors.initials: GL
authors.lastname: Michelis
authors.forename: Manuela
authors.initials: M
authors.lastname: Balocco
authors.forename: Nabila
authors.initials: N
authors.lastname: Abdall
authors.forename: Simona
authors.initials: S
authors.lastname: Gatto
authors.forename: Marco
authors.initials: M
authors.lastname: Gobbi
mesh_terms: D000328:Adult; D003561:Cytarabine / Q000627:therapeutic use*; D003630:Daunorubicin / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D008081:Liposomes / Q000008:administration & dosage*; D008875:Middle Aged; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000473:pathology; D016879:Salvage Therapy; D016896:Treatment Outcome; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*
chemical_list: D008081:Liposomes; D003561:Cytarabine; D014740:Vidarabine; C024352:fludarabine; D003630:Daunorubicin